Paclitaxel Plus Ramucirumab Versus Paclitaxel Alone In Patients With Squamous-Cell Carcinoma Of The Esophagus, Refractory Or Intolerant To Combination Therapy With Fluoropyrimidine And Platinum-Based Drugs - Ramos, A Randomized Phase Ii Trial Of The German Gastric Group Of The Aio
Annals of Oncology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要